Sub-Investigator PQ-110-001. A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of EXN407 in Subjects with Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus